|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.00 USD | -7.14% |
|
-.--% | - |
| Dec. 29 | Merus N.V.(NasdaqGM:MRUS) dropped from NASDAQ Composite Index | CI |
| Dec. 29 | Genmab scraps development of experimental cancer therapy | RE |
| Market Cap | 6.83B 5.97B 5.52B 5.06B 9.58B 658B 9.75B 65.81B 25.85B 321B 25.64B 25.07B 1,109B | P/E 2026 * |
-15.2x | P/E 2027 * | -19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.83B 5.97B 5.52B 5.06B 9.58B 658B 9.75B 65.81B 25.85B 321B 25.64B 25.07B 1,109B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
96.03% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.14% |
| 1 year | 61.32 |  | 97.14 |
| 3 years | 19.8 | | 97.14 |
| 5 years | 12.03 | | 97.14 |
| 10 years | 8 | | 97.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2025-12-11 | |
Gregory Perry
DFI | Director of Finance/CFO | 65 | 2023-06-13 |
Fabian Zohren
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2025-12-11 | |
| Director/Board Member | 54 | 2025-12-11 | |
Anthony Pagano
BRD | Director/Board Member | 48 | 2025-12-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/26/25 | Buy | Company | 76,922,983 | 101.4184% | ||
| 12/22/25 | Buy | Company | 815,444 | 1.0751% | ||
| 12/18/25 | Buy | Company | 278,441 | 0.3671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.14% | -.--% | +59.28% | +229.79% | 6.83B | |
| -3.42% | +4.90% | +61.15% | +87.70% | 55.98B | |
| -0.24% | -1.94% | +52.61% | +71.16% | 53.69B | |
| +2.54% | -4.95% | +5.49% | +430.87% | 23.29B | |
| -0.31% | -0.16% | -17.74% | -14.80% | 23.15B | |
| -5.95% | -2.58% | +30.67% | -9.47% | 20.58B | |
| -0.41% | +0.54% | +32.24% | -30.06% | 17.76B | |
| -4.55% | -1.95% | +192.65% | +349.58% | 16.09B | |
| -6.91% | -5.83% | +26.53% | +644.30% | 15.93B | |
| -0.31% | -1.70% | +23.78% | +189.42% | 14B | |
| Average | -2.63% | -0.39% | +46.67% | +194.85% | 24.73B | |
| Weighted average by Cap. | -2.05% | -0.86% | +46.21% | +152.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -462M -404M -373M -343M -649M -44.52B -660M -4.45B -1.75B -21.74B -1.73B -1.7B -75.05B | -435M -380M -352M -323M -611M -41.92B -621M -4.19B -1.65B -20.47B -1.63B -1.6B -70.67B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MRUS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
